ReviewPharmacology & therapeutics2023
RET aberrant cancers and RET inhibitor therapies: Current state-of-the-art and future perspectives.
Alfredo Addeo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
24 papers cite it
this papertrialcites it